105 related articles for article (PubMed ID: 20732423)
1. Amyloid precursor-like protein 2 cleavage contributes to neuronal intranuclear inclusions and cytotoxicity in spinocerebellar ataxia-7 (SCA7).
Takahashi-Fujigasaki J; Breidert T; Fujigasaki H; Duyckaerts C; Camonis JH; Brice A; Lebre AS
Neurobiol Dis; 2011 Jan; 41(1):33-42. PubMed ID: 20732423
[TBL] [Abstract][Full Text] [Related]
2. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
Chort A; Alves S; Marinello M; Dufresnois B; Dornbierer JG; Tesson C; Latouche M; Baker DP; Barkats M; El Hachimi KH; Ruberg M; Janer A; Stevanin G; Brice A; Sittler A
Brain; 2013 Jun; 136(Pt 6):1732-45. PubMed ID: 23518714
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
[TBL] [Abstract][Full Text] [Related]
4. gamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteins.
Walsh DM; Fadeeva JV; LaVoie MJ; Paliga K; Eggert S; Kimberly WT; Wasco W; Selkoe DJ
Biochemistry; 2003 Jun; 42(22):6664-73. PubMed ID: 12779321
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.
Janer A; Werner A; Takahashi-Fujigasaki J; Daret A; Fujigasaki H; Takada K; Duyckaerts C; Brice A; Dejean A; Sittler A
Hum Mol Genet; 2010 Jan; 19(1):181-95. PubMed ID: 19843541
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.
Mookerjee S; Papanikolaou T; Guyenet SJ; Sampath V; Lin A; Vitelli C; DeGiacomo F; Sopher BL; Chen SF; La Spada AR; Ellerby LM
J Neurosci; 2009 Dec; 29(48):15134-44. PubMed ID: 19955365
[TBL] [Abstract][Full Text] [Related]
7. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
[TBL] [Abstract][Full Text] [Related]
8. BACE (beta-secretase) modulates the processing of APLP2 in vivo.
Pastorino L; Ikin AF; Lamprianou S; Vacaresse N; Revelli JP; Platt K; Paganetti P; Mathews PM; Harroch S; Buxbaum JD
Mol Cell Neurosci; 2004 Apr; 25(4):642-9. PubMed ID: 15080893
[TBL] [Abstract][Full Text] [Related]
9. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
10. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
12. Autophagy: polyQ toxic fragment turnover.
Duncan C; Papanikolaou T; Ellerby LM
Autophagy; 2010 Feb; 6(2):312-4. PubMed ID: 20104018
[TBL] [Abstract][Full Text] [Related]
13. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
14. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.
Yvert G; Lindenberg KS; Devys D; Helmlinger D; Landwehrmeyer GB; Mandel JL
Hum Mol Genet; 2001 Aug; 10(16):1679-92. PubMed ID: 11487572
[TBL] [Abstract][Full Text] [Related]
15. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3.
Zander C; Takahashi J; El Hachimi KH; Fujigasaki H; Albanese V; Lebre AS; Stevanin G; Duyckaerts C; Brice A
Hum Mol Genet; 2001 Oct; 10(22):2569-79. PubMed ID: 11709544
[TBL] [Abstract][Full Text] [Related]
16. Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons.
Wang HL; Chou AH; Lin AC; Chen SY; Weng YH; Yeh TH
Exp Neurol; 2010 Aug; 224(2):486-94. PubMed ID: 20546728
[TBL] [Abstract][Full Text] [Related]
17. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
Kawabata S; Higgins GA; Gordon JW
Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
[TBL] [Abstract][Full Text] [Related]
18. Signaling via amyloid precursor-like proteins APLP1 and APLP2.
Orcholski ME; Zhang Q; Bredesen DE
J Alzheimers Dis; 2011; 23(4):689-99. PubMed ID: 21178287
[TBL] [Abstract][Full Text] [Related]
19. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.
Michalik A; Martin JJ; Van Broeckhoven C
Eur J Hum Genet; 2004 Jan; 12(1):2-15. PubMed ID: 14571264
[TBL] [Abstract][Full Text] [Related]
20. A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes.
Latouche M; Lasbleiz C; Martin E; Monnier V; Debeir T; Mouatt-Prigent A; Muriel MP; Morel L; Ruberg M; Brice A; Stevanin G; Tricoire H
J Neurosci; 2007 Mar; 27(10):2483-92. PubMed ID: 17344386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
